MACC1 and neoplasm: At the experimental endpoint (tumor burden), the signals in the livers of FLO-1/MACC1/Luc-cell-transplanted animals (6.48 × 108 RLU) exceeded the signals of the control animals (3.29 × 108 RLU, p = 0.0823) by nearly two-fold (Figure 4A).